Casey Logan
Corporate Officer/Principal chez TRAVERE THERAPEUTICS, INC.
Profil
Casey H.
Logan is currently the Director at Memgen, Inc. and the Chief Business Officer at Travere Therapeutics, Inc. Previously, Casey held positions as the Director of Business Development & Senior Manager at Eli Lilly & Co., Vice President of Development & Strategic Planning at Anadys Pharmaceuticals, Inc., Chief Business Officer at TRACON Pharmaceuticals, Inc., and Senior Vice President of Development at Bird Rock Bio Sub, Inc. Casey obtained an undergraduate degree from the University of Michigan and an MBA from Kellogg School of Management.
Postes actifs de Casey Logan
| Sociétés | Poste | Début |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Corporate Officer/Principal | 05/03/2018 |
Memgen, Inc.
 Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Directeur/Membre du Conseil | - |
Anciens postes connus de Casey Logan
| Sociétés | Poste | Fin |
|---|---|---|
| TRACON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 02/03/2018 |
Bird Rock Bio, Inc.
 Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Corporate Officer/Principal | - |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Corporate Officer/Principal | 01/01/2010 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2007 |
Formation de Casey Logan
| University of Michigan | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| TRACON PHARMACEUTICALS, INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| TRAVERE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Bird Rock Bio, Inc.
Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Health Technology |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Health Technology |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Health Technology |
